Behind the markets

Blog

Our #1 Biotech Stock For November – Mirati Therapeutics (MRTX)

KRAS is one of the most frequently mutated genes in non-small cell lung cancer (NSCLC), found in approximately 30% of lung adenocarcinomas, and is thus an appealing target for new therapies.

September 2022 Issue: Mirati Therapeutics (SYM: MRTX)

Today I want to talk to you about KRAS mutations in cancer treatment. But first, we have three stocks to sell today. We’ll be taking profits on two and a loss on one.

October 2020 Issue: Life on Top – Mirati Therapeutics

Our #1 Biotech Stock For November – Mirati Therapeutics (MRTX)

KRAS is one of the most frequently mutated genes in non-small cell lung cancer (NSCLC), found in approximately 30% of lung adenocarcinomas, and is thus an appealing target for new therapies.

September 2022 Issue: Mirati Therapeutics (SYM: MRTX)

Today I want to talk to you about KRAS mutations in cancer treatment. But first, we have three stocks to sell today. We’ll be taking profits on two and a loss on one.

October 2020 Issue: Life on Top – Mirati Therapeutics

Categories

Recent posts

Tags

Connect with Us

Get FREE Weekly Stock Tips

Join and receive market insider stock picks, trade alerts and unique investing insights
This field is for validation purposes and should be left unchanged.
By clicking the "Subscribe" button you are accepting our Terms of Use and Privacy Policy.

Join Waitlist

We’re sorry, but due to the popularity of our services, we have reached our max number of subscribers and are not currently accepting more. If spots become available, we will be sure to contact you. Please join the waitlist below.
Thank You!

"*" indicates required fields

Name*

You applied for

Hidden Market Profits

Platinum

$99

This field is for validation purposes and should be left unchanged.